UCB launches Neupro in US pharmacies to treat Parkinson’s disease & RLS – pharmabiz.com

by admin on August 15, 2012


Parkinson’s Disease News
UCB launches Neupro in US pharmacies to treat Parkinson's disease & RLS
pharmabiz.com
Neupro was recently approved by the US Food and Drug Administration (FDA) in April to treat the signs and symptoms of early and advanced stage idiopathic Parkinson's disease and moderate-to-severe primary Restless Legs Syndrome. Neupro improves
UCB unveils Neupro drug in US marketPharmaceutical Business Review
UCB launches Neupro transdermal patchDrug Store News
UCB's Neupro re-launched in USA for Parkinson's and RSLThe Pharma Letter
NASDAQ
all 29 news articles »

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: